End-stage kidney disease and rationing of kidney replacement therapy in the free state province, South Africa: a retrospective study

被引:4
|
作者
Molaoa, Thabang T. [1 ]
Bisiwe, Feziwe B. [1 ]
Ndlovu, Kwazi C. Z. [2 ,3 ]
机构
[1] Univ Free State, Div Nephrol, Dept Internal Med, Bloemfontein, South Africa
[2] Univ Cape Town, Div Nephrol & Hypertens, Cape Town, South Africa
[3] Univ Cape Town, Kidney & Hypertens Res Unit, Cape Town, South Africa
关键词
Incidence rate; End-stage kidney disease; Kidney replacement therapy; Dialysis access; South Africa; SUB-SAHARAN-AFRICA; RENAL-DISEASE; PERITONEAL-DIALYSIS; HEALTH-CARE; TRANSPLANTATION; PREVENTION; PREVALENCE; OUTCOMES; OLDER; HIV;
D O I
10.1186/s12882-021-02387-x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background End-stage kidney disease (ESKD) and the required kidney replacement therapy (KRT) are significant public health challenges for low-and-middle-income countries. The South African government adopted a KRT rationing policy to balance the growing need for KRT and scarce resources. We aimed to describe the epidemiology and KRT access in patients with ESKD referred to the main public sector hospital in the Free State Province, South Africa. Methods A retrospective study of adult patients with ESKD admitted to Universitas Academic Hospital for KRT, was conducted between 1 January 2016 and 31 December 2018. A review of the KRT committee decisions to offer or deny KRT based on the KRT rationing policy of the Free State was undertaken. Demographic information, KRT committee outcomes, laboratory test results, and clinical details were collected from assessment tools, KRT committee meeting diaries, and electronic hospital records. Results Of 363 patients with ESKD referred for KRT access, 96 with incomplete records were excluded and 267 were included in the analysis. Median patient age was 40 (interquartile range, 33-49) years, and male patients accounted for 56.2 % (150/267, p = 0.004) of the cohort. The average annual ESKD incidence was 49.9 (95 % confidence interval [CI], 35.8-64.0) per-million-population. The most prevalent comorbidities were hypertension (42.3 %; 113/267), human immunodeficiency virus (HIV) (28.5 %; 76/267), and diabetes mellitus (19.1 %; 51/267). The KRT access rate was 30.7 % (82/267), with annual KRT incidence rates of 8.05 (95 % CI, 4.98-11.1), 11.5 (95 % CI, 7.83-15.1), and 14.1 (95 % CI, 10.3-18.0) per-million-population in 2016, 2017, and 2018, respectively. Advanced organ dysfunction was the commonest reason recorded for KRT access denial (58.9 %; 109/185). Age (odds ratio [OR], 1.04; 95 % CI, 1.00-1.07; p = 0.024) and diabetes (OR, 5.04; CI, 1.69-15.03; p = 0.004) were independent predictors for exclusion from KRT, while hypertension (OR, 1.80; 1.06-3.04; p = 0.029) independently predicted advanced organ dysfunction resulting in KRT exclusion. Conclusions Non-communicable and communicable diseases, including hypertension, diabetes, and HIV, contributed to ESKD, highlighting the need for improved early prevention strategies to address a growing incidence rate. Two-thirds of ESKD patients were unable to access KRT, with age, diabetes mellitus, and advanced organ dysfunction being significant factors adversely affecting KRT access.
引用
收藏
页数:12
相关论文
共 50 条
  • [11] Outcomes of rationing dialysis therapy in biopsy-proven end-stage renal disease in South Africa
    Okpechi, Ikechi G.
    Swanepoel, Charles R.
    Rayner, Brian L.
    JOURNAL OF NEPHROLOGY, 2012, 25 (04) : 551 - 557
  • [12] IS KIDNEY TRANSPLANTATION IN END-STAGE RENAL DISEASE PATIENTS OVER 75 A SAFE AND EFFECTIVE KIDNEY REPLACEMENT THERAPY?
    Gigante, Marc
    Mazzola, Clarisse
    Lefrancois, Nicole
    Tillou, Xavier
    Neuzillet, Yann
    TRANSPLANT INTERNATIONAL, 2012, 25 : 49 - 49
  • [13] INCIDENCE AND OUTCOMES OF KIDNEY REPLACEMENT THERAPY FOR END-STAGE KIDNEY DISEASE DUE TO PRIMARY GLOMERULONEPHRITIS IN THE ERA REGISTRY
    Elhafeez, Samar Abd
    Kramer, Anneke
    Pippias, Maria
    Ortiz, Alberto
    Jager, Kitty J.
    Stel, Vianda
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I19 - I19
  • [14] Epidemiology of End-Stage Kidney Disease on Renal Replacement Therapy: 35 Years Analysis Study Nephrologists
    Al-Za'abi, Ruqiya
    Tolmie, Elizabeth P.
    Rice, Ann Marie
    Mohsin, Nabil
    Al-Busadi, Ahmed Said
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2021, 32 (01) : 183 - 190
  • [15] Xenotransplantation of a Porcine Kidney for End-Stage Kidney Disease
    Kawai, Tatsuo
    Williams, Winfred W.
    Elias, Nahel
    Fishman, Jay A.
    Crisalli, Kerry
    Longchamp, Alban
    Rosales, Ivy A.
    Duggan, Michael
    Kimura, Shoko
    Morena, Leela
    Borges, Thiago J.
    Tomosugi, Toshihide
    Karadagi, Ahmad
    Nakamura, Tsukasa
    Safa, Kassem
    Giarraputo, Alessia
    Avillach, Claire T.
    Patalas, Eva D.
    Smith, R. Neal
    Sachs, David H.
    Cosimi, A. Benedict
    Madsen, Joren C.
    Cooper, David K. C.
    Pierson, Richard
    Perrin, Steve
    Anand, Ranjith P.
    Chhangawala, Sagar
    Coscarella, Matthew
    Daigneault, Alexandre
    Li, Feng
    Pearce, Owen
    Qin, Wenning
    Serkin, William T.
    Yeung, Vincent
    Getchell, Kristen
    Low, Susan C.
    Curtis, Michael
    Colvin, Robert B.
    Riella, Leonardo V.
    NEW ENGLAND JOURNAL OF MEDICINE, 2025,
  • [16] Treatment of End-stage Kidney Failure without Renal Replacement Therapy
    Hole, Barnaby
    Tonkin-Crine, Sarah
    Caskey, Fergus J.
    Roderick, Paul
    SEMINARS IN DIALYSIS, 2016, 29 (06) : 491 - 506
  • [17] Endotoxemia in End-Stage Kidney Disease
    Wong, Jonathan
    Vilar, Enric
    Farrington, Ken
    SEMINARS IN DIALYSIS, 2015, 28 (01) : 59 - 67
  • [18] End-stage Kidney Disease Doubles
    Kuehn, Bridget M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (16): : 1540 - 1540
  • [19] Epidemiology of end-stage kidney disease
    Gupta, Ryan
    Woo, Karen
    Yi, Jeniann A.
    SEMINARS IN VASCULAR SURGERY, 2021, 34 (01) : 71 - 78
  • [20] PATHOLOGY OF END-STAGE KIDNEY DISEASE
    HEPTINSTALL, RH
    AMERICAN JOURNAL OF MEDICINE, 1968, 44 (05): : 656 - +